Login / Signup
Absence of cross-toxicity between MET inhibitors in a non-small-cell lung cancer with a MET exon 14 skipping mutation.
Ariane Vanderick
Benoît Colinet
Published in:
Acta clinica Belgica (2024)
This is the first case showing the absence of cross-toxicity between 1b MET inhibitors.
Keyphrases
</>
tyrosine kinase
oxidative stress